Home >> Research Area >>GPCR/G protein>>P2Y Receptor>> MRS 2957 triethylammonium salt

MRS 2957 triethylammonium salt

Potent and selective P2Y6 agonist CAS# 1228271-30-4

MRS 2957 triethylammonium salt

Catalog No. BCC6133----Order now to get a substantial discount!

Product Name & Size Price Stock
MRS 2957 triethylammonium salt: 5mg $1817 In Stock
MRS 2957 triethylammonium salt: 10mg Please Inquire In Stock
MRS 2957 triethylammonium salt: 20mg Please Inquire Please Inquire
MRS 2957 triethylammonium salt: 50mg Please Inquire Please Inquire
MRS 2957 triethylammonium salt: 100mg Please Inquire Please Inquire
MRS 2957 triethylammonium salt: 200mg Please Inquire Please Inquire
MRS 2957 triethylammonium salt: 500mg Please Inquire Please Inquire
MRS 2957 triethylammonium salt: 1000mg Please Inquire Please Inquire
Related Products

Quality Control of MRS 2957 triethylammonium salt

Number of papers citing our products

Chemical structure

MRS 2957 triethylammonium salt

3D structure

Chemical Properties of MRS 2957 triethylammonium salt

Cas No. 1228271-30-4 SDF Download SDF
PubChem ID 90488923 Appearance Powder
Formula C37H73N8O20P3 M.Wt 1042.94
Type of Compound N/A Storage Desiccate at -20°C
Solubility Soluble in water (supplied pre-dissolved at a concentration of 10mM)
Chemical Name [[(2R,3S,4R,5R)-3,4-dihydroxy-5-[4-(methoxyamino)-2-oxopyrimidin-1-yl]oxolan-2-yl]methoxy-oxidophosphoryl] [[(2S,3R,4S,5S)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl] phosphate;triethylazanium
SMILES CC[NH+](CC)CC.CC[NH+](CC)CC.CC[NH+](CC)CC.CONC1=NC(=O)N(C=C1)C2C(C(C(O2)COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])OCC3C(C(C(O3)N4C=CC(=O)NC4=O)O)O)O)O
Standard InChIKey UCQYWKBGVXRIQK-BJFMRLMLSA-N
Standard InChI InChI=1S/C19H28N5O20P3.3C6H15N/c1-38-22-10-2-4-23(18(30)20-10)16-14(28)12(26)8(41-16)6-39-45(32,33)43-47(36,37)44-46(34,35)40-7-9-13(27)15(29)17(42-9)24-5-3-11(25)21-19(24)31;3*1-4-7(5-2)6-3/h2-5,8-9,12-17,26-29H,6-7H2,1H3,(H,32,33)(H,34,35)(H,36,37)(H,20,22,30)(H,21,25,31);3*4-6H2,1-3H3/t8-,9+,12-,13+,14-,15+,16-,17+;;;/m1.../s1
General tips For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months.
We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months.
Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it.
About Packaging 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial.
2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial.
3. Try to avoid loss or contamination during the experiment.
Shipping Condition Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request.

Biological Activity of MRS 2957 triethylammonium salt

DescriptionPotent P2Y6 agonist (EC50 = 12 nM). Displays 14- and 66-fold selectivity against P2Y2 and P2Y4 receptors respectively.

MRS 2957 triethylammonium salt Dilution Calculator

Concentration (start)
x
Volume (start)
=
Concentration (final)
x
Volume (final)
 
 
 
C1
V1
C2
V2

calculate

MRS 2957 triethylammonium salt Molarity Calculator

Mass
=
Concentration
x
Volume
x
MW*
 
 
 
g/mol

calculate

Preparing Stock Solutions of MRS 2957 triethylammonium salt

1 mg 5 mg 10 mg 20 mg 25 mg
1 mM 0.9588 mL 4.7941 mL 9.5883 mL 19.1766 mL 23.9707 mL
5 mM 0.1918 mL 0.9588 mL 1.9177 mL 3.8353 mL 4.7941 mL
10 mM 0.0959 mL 0.4794 mL 0.9588 mL 1.9177 mL 2.3971 mL
50 mM 0.0192 mL 0.0959 mL 0.1918 mL 0.3835 mL 0.4794 mL
100 mM 0.0096 mL 0.0479 mL 0.0959 mL 0.1918 mL 0.2397 mL
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations.

Organizitions Citing Our Products recently

 
 
 

Calcutta University

University of Minnesota

University of Maryland School of Medicine

University of Illinois at Chicago

The Ohio State University

University of Zurich

Harvard University

Colorado State University

Auburn University

Yale University

Worcester Polytechnic Institute

Washington State University

Stanford University

University of Leipzig

Universidade da Beira Interior

The Institute of Cancer Research

Heidelberg University

University of Amsterdam

University of Auckland
TsingHua University
TsingHua University
The University of Michigan
The University of Michigan
Miami University
Miami University
DRURY University
DRURY University
Jilin University
Jilin University
Fudan University
Fudan University
Wuhan University
Wuhan University
Sun Yat-sen University
Sun Yat-sen University
Universite de Paris
Universite de Paris
Deemed University
Deemed University
Auckland University
Auckland University
The University of Tokyo
The University of Tokyo
Korea University
Korea University
Featured Products
New Products
 

References on MRS 2957 triethylammonium salt

Pyrimidine ribonucleotides with enhanced selectivity as P2Y(6) receptor agonists: novel 4-alkyloxyimino, (S)-methanocarba, and 5'-triphosphate gamma-ester modifications.[Pubmed:20446735]

J Med Chem. 2010 Jun 10;53(11):4488-501.

The P2Y(6) receptor is a cytoprotective G-protein-coupled receptor (GPCR) activated by UDP (EC(50) = 0.30 microM). We compared and combined modifications to enhance P2Y(6) receptor agonist selectivity, including ribose ring constraint, 5-iodo and 4-alkyloxyimino modifications, and phosphate modifications such as alpha,beta-methylene and extension of the terminal phosphate group into gamma-esters of UTP analogues. The conformationally constrained (S)-methanocarba-UDP is a full agonist (EC(50) = 0.042 microM). 4-Methoxyimino modification of pyrimidine enhanced P2Y(6), preserved P2Y(2) and P2Y(4), and abolished P2Y(14) receptor potency, in the appropriate nucleotide. N(4)-Benzyloxy-CDP (15, MRS2964) and N(4)-methoxy-Cp(3)U (23, MRS2957) were potent, selective P2Y(6) receptor agonists (EC(50) of 0.026 and 0.012 microM, respectively). A hydrophobic binding region near the nucleobase was explored with receptor modeling and docking. UTP-gamma-aryl and cycloalkyl phosphoesters displayed only intermediate P2Y(6) receptor potency but had enhanced stability in acid and cell membranes. UTP-glucose was inactive, but its (S)-methanocarba analogue and N(4)-methoxycytidine 5'-triphospho-gamma-[1]glucose were active (EC(50) of 2.47 and 0.18 microM, respectively). Thus, the potency, selectivity, and stability of pyrimidine nucleotides as P2Y(6) receptor agonists may be enhanced by modest structural changes.

Keywords:

MRS 2957 triethylammonium salt,1228271-30-4,Natural Products,P2Y Receptor, buy MRS 2957 triethylammonium salt , MRS 2957 triethylammonium salt supplier , purchase MRS 2957 triethylammonium salt , MRS 2957 triethylammonium salt cost , MRS 2957 triethylammonium salt manufacturer , order MRS 2957 triethylammonium salt , high purity MRS 2957 triethylammonium salt

Online Inquiry for:

      Fill out the information below

      • Size:Qty: - +

      * Required Fields

                                      Result: